References
1. Recurrent Pregnancy Loss. Guideline of the European Society of Human Reproduction and Embryology 2017. November 2017.
2. Miscarriage in early pregnancy: diagnosis and management tactics. Clinical guidelines (Treatment protocol). Letter of the Ministry of Health No. 15-4/10/2-3482 dated June 07, 2016 (in Russian)
3. Karp G.J.A. (ed.) / Habitual miscarriage. Reasons, versions and contra-versions, treatment / per. from English. ; ed. V.E. Radzinsky. Moscow, 2017: 31-5. (in Russian)
4. Manuhin I.B., Dobrohotova Yu.E., Kuleshov V.M., Tshay V.B., Tapilskaya N.I., Rogozhina I.E., et al. Therapy for threatened miscarriage with micronized progesterone and dydrogesterone (results of multicenter open prospective comparative non-interventional study). Problemy reproduktsii [Problems of Reproduction]. 2018; 24 (3): 34-42. (in Russian)
5. Scarpellini F. The role of filgrastim in recurrent pregnancy loss. In: International Conference on Paradigm Changes in the Management of Early Pregnancy and Pregnancy Loss. London, UK, February 21-24, 2019.
6. Simonovskaya Kh.Yu., Aleev I.A. Information mail. Miscarriage: the evidence base for dydrogesterone. News of evidence-based medicine of dydrogesterone for the prevention and treatment of miscarriage. Edit. by V.E. Radzinsky. Moscow: Redaktsiya zhurnala StatusPraesens, 2015: 24 p. (in Russian)
7. Esareva A.V., Bashmakova N.V., Melkozerova O.A. Method of restoring endometrial receptivity in women with uterine infertility using a cavitated solution of granulocyte colony-stimulating growth factor. Invention patent RU 2 667 611 C1. 2018. (in Russian)
8. Scarpellini F., Klinger F.G., Rossi G., Sbracia M. Immunohistochemical study on the expression of G-CSF, G-CSFR, VEGF, VEGFR-1, Foxp3 in first trimester tropho-blast of recurrent pregnancy loss in pregnancies treated with G-CSF and controls. Int J Mol Sci. 2019; 21 (1). DOI: https://doi.org/10.3390/ijms21010285
9. Coulam C.B. Does immunotherapy for treatment of reproductive failure enhance live births? Am J Reprod Immunol. 2012; 67: 296-304.
10. Rocha M.N.C., Florencio R.S., Alves R.R.F. The role played by granulocyte colony stimulating factor (G-CSF) on women submitted to in vitro fertilization associated with thin endometrium: systematic review. JBRA Assist Reprod. 2020 Apr 15. DOI: https://doi.org/10.5935/1518-0557.20200026
11. Sarvi F., Arabahmadi M., Alleyassin A., Aghahosseini M., Ghasemi M. Effect of increased endometrial thickness and implantation rate by granulocyte colony-stimulating factor on unresponsive thin endometrium in fresh in vitro fertilization cycles: a randomized clinical trial. Obstet Gynecol Int. 2017; 2017: 3596079. DOI: https://doi.org/10.1155/2017/3596079
12. Zhang L., Xu W.H., Fu X.H., Huang Q.X., Guo X.Y., Zhang L., et al. Therapeutic role of granulocyte colony-stimulating factor (G-CSF) for infertile women under in vitro fertilization and embryo transfer (IVF-ET) treatment: a meta-analysis. Arch Gynecol Obstet. 2018; 298 (5): 861-71. DOI: https://doi.org/10.1007/s00404-018-4892-4
13. Zeyneloglu H.B., Tohma Y.A., Onalan G., Moran U. Granulocyte colony-stimulating factor for intracytoplasmic sperm injection patients with repeated implantation failure: which route is best? J Obstet Gynaecol. 2020; 40 (4): 526-30. DOI: https://doi.org/10.1080/01443615.2019.1631772 Epub 2019 Sep 9.
14. Jain S., Mahey R., Malhotra N., Kalaivani M., Sangeeta P., Bhatt A., et al. Effect of intrauterine perfusion of granulocyte colony-stimulating factor on endometrial parameters and in vitro fertilization outcome in women undergoing in vitro fertiliza-tion/intracytoplasmic sperm injection cycles: a randomized controlled trial. J Hum Re-prod Sci. 2018; 11 (3): 254-60. DOI: https://doi.org/10.4103/jhrs
15. Barad D.H., Yu Y., Kushnir V.A., Shohat-Tal A., Lazzaroni E., Lee H.J., et al. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates. Fertil Steril. 2016; 101 (3): 710-5.